Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda in advanced penile squamous cell carcinoma
NCT02837042Phase 2Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2016
- Primary completion
- Oct 2019
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in penile squamous cell carcinoma (PSCC), sponsored by University of Alabama at Birmingham. Started Oct 2016; status: terminated.
02
Drugs
03
Conditions
penile squamous cell carcinoma (PSCC)
Beyond the preview
Go deeper on NCT02837042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02837042.